Mobile Menu - OpenMobile Menu - Closed

Markup of H.R. 1222, H.R. 2410, and H.R. ____, FDA Reauthorization Act of 2017, Subcommittee on Health (May 18, 2017)

Thursday, May 18, 2017 - 10:00am
2123 Rayburn House Office Building

The Subcommittee on Health met in open markup session on Thursday, May 18, 2017, at 10:00 a.m., in 2123 Rayburn House Office Building.





Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Health 

Opening Statement of Ranking Member Pallone as prepared for delivery



H.R. 1222, To amend the Public Health Service Act to coordinate Federal congenital heart disease research efforts and to improve public education and awareness of congenital heart disease, and for other purposes. 

Amendment in the Nature of a Substitute to H.R. 1222, filed by Rep. Bilirakis


H.R. 2410, To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment. 


H.R. 2430  FDA Reauthorization Act of 2017, To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.